ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

NCI Programs: Advisors Approve concept For Spiral CT Image Database Consortium

November 12, 1999